Triathlon® Cruciate Retaining (CR) Total Knee System Outcomes Study

A Post-market, Non-randomized, Historical Controlled, Multi-center Study of the Outcomes of the Triathlon® Cruciate Retaining (CR) Total Knee System

The purpose of this study is to evaluate the clinical outcomes (range of motion, pain, function, radiographic stability, and health related quality of life) of patients receiving the Triathlon® Cruciate Retaining (CR) Total Knee System. These outcomes will be evaluated by comparing pre-operative to post-operative scores, as well as to a control group. The control group is the Scorpio® CR Total Knee System.

Study Overview

• Status: Completed
• Conditions: Arthroplasty, Replacement, Knee
• Intervention / Treatment: Device: Triathlon® CR Total Knee System

Detailed Description

The Triathlon® Cruciate Retaining (CR) Total Knee System components are for use in cemented total knee arthroplasty for painful, disabling joint disease of the knee resulting from non-inflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis or avascular necrosis) or rheumatoid arthritis (excluded from this study according to protocol). The components are designed to improve range of motion (ROM) and stability. This study serves to demonstrate that subjects have reduced pain, increased ROM and improved stability following implantation with the Triathlon Cruciate Retaining (CR) Total Knee System as compared to the historical control.

• Study Type: Interventional
• Enrollment (Actual): 419
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Arizona
    • Phoenix, Arizona, United States, 85016
      • Arizona Institute for Bone and Joint Disorders
  • Florida
    • Miami, Florida, United States, 33136
      • Cedars Medical Center University of Miami
  • Georgia
    • Columbus, Georgia, United States, 31908
      • Hughston Sports Medicine Center
  • Iowa
    • Cedar Rapids, Iowa, United States, 52401
      • Physician's Clinic of Iowa, Mercy Medical Center
  • Massachusetts
    • Newton, Massachusetts, United States, 02462
      • Newton Wellesley Hospital
  • New York
    • Buffalo, New York, United States, 14203
      • Buffalo General Hospital, Department of Orthopaedics Kaleida Health
  • Ohio
    • Akron, Ohio, United States, 44330
      • Crystal Clinic
  • Oregon
    • Bend, Oregon, United States, 97701
      • The Center: Orthopaedic & Neurosurgical Care & Research
  • Tennessee
    • Knoxville, Tennessee, United States, 37909
      • Knoxville Orthopaedic Clinic
  • Texas
    • Temple, Texas, United States, 76508
      • Scott & White Memorial Hospital
  • Wisconsin
    • Milwaukee, Wisconsin, United States, 53233
      • Aurora Advanced Healthcare

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. The subject is a male or non-pregnant female between the ages of 21 and 80.
2. The subject requires a primary cemented total knee replacement.
3. The subject has a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN).
4. The subject has intact collateral ligaments.
5. The subject has signed the IRB-approved, study specific Informed Patient Consent Form.
6. The subject is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion Criteria:

1. Patient has inflammatory arthritis.
2. The subject is morbidly obese, BMI > 40.
3. The subject has a history of total or unicompartmental reconstruction of the affected joint.
4. Patient has had a high tibial osteotomy or femoral osteotomy.
5. The subject has no obvious charcot (i.e. a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device).
6. The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
7. The subject is immunologically suppressed, or receiving chronic steroids (> 30 days duration).
8. The subject's bone stock is compromised by disease or infection, which cannot provide adequate support and/or fixation to the prothesis.
9. The subject has had a knee fusion to the affected joint.
10. The subject has an active or suspected latent infection in or about the knee joint.
11. The subject is a prisoner.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Triathlon® CR Total Knee System; Participants receive the Triathlon® CR Total Knee System	Device: Triathlon® CR Total Knee System; The purpose is to evaluate the Triathlon® CR Total Knee System.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Active Range of Motion	2 Years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Knee Society Score (KSS) Over Time	The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, ROM and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome.	preoperative, 1, 2, and 5 years
Active Flexion, Passive Flexion, Active Extension, and Passive Extension Range of Motion (ROM)	Knee range of motion is measured by the number of degrees flexion and extension observed. Active motion is the number of degrees that a participant can extend and flex their knee independently. Passive motion is the number of degrees that an examiner is able to extend and flex the knee without the assistance of the participant. The Knee Society Score range of motion utilized for this study defines the range from 0 degrees of extension to 125 degrees of flexion.	1, 2, and 5 years
Number of Knees With Radiographic Failure Assessed Via the Knee Society Total Knee Arthroplasty Roentgenographic Score	Parameters for radiographic failures will follow the guidelines that have been set by the Knee Society. The scoring system for each of the three components is determined by measuring the width of the radiolucent lines for each of the zones in millimeters for each of the three components. The total widths in millimeters are added for each zone for each of the three prostheses. The total produces a numerical score for each component. Failure is defined as a score of 10 or greater, regardless of symptoms.	1, 2, and 5 years
Change in SF-36 Health Survey Over Time	The SF-36 Health Survey is a 36 item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.	preoperative, 1, 2, 3, 4, and 5 years
Change in Western Ontario and McMaster Osteoarthritis Index (WOMAC) Over Time	The WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes.	preoperative,1, 2, 3, 4 and 5 years
Change in Lower-Extremity Activity Scale (LEAS) Over Time	The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.	preoperative, 1, 2, 3, 4, and 5 years
Patellar Subluxation, Dislocation and Fracture Rate	The incidence of patellar subluxation, dislocation or fracture is reported.	5 years
Patient Outcome Long Term Follow-up Questionnaire Over Time	Patient-reported outcome is collected using a long-term follow-up questionnaire at 6, 7, 8, 9, and 10 years postoperative for the subjects who consent to participation in the long-term follow-up study. The questionnaire consists of three yes or no questions: Do you have any pain in your knee that has the study knee replacement?; Are you satisfied with the results of your study total knee replacement?; Have you had any surgery on your study knee since the time of your last study required visit/contact?	6, 7, 8, 9, and 10 years
Implant Survivorship	Implant survivorship at 10 years postoperative is determined using the Kaplan-Meier method.	10 years

Collaborators and Investigators

• Sponsor: Stryker Orthopaedics
• Investigators: Principal Investigator: Kirby Hitt, MD, Scott & White Memorial Hospital; Principal Investigator: Knute Buehler, MD, The Center: Orthopaedic & Neurosurgical Care & Research; Principal Investigator: Brian Covino, MD, Knoxville Orthopedic Clinic; Principal Investigator: Joseph Davies, MD, Aurora Advanced Healthcare; Study Chair: Kenneth Greene, MD, Crystal Clinic; Principal Investigator: Anthony Hedley, MD, Arizona Institute for Bone and Joint Disorders; Principal Investigator: Joseph McCarthy, MD, Newton-Wellesley Hospital; Principal Investigator: Jeffrey Nassif, MD, Physician's Clinic of Iowa, PC; Principal Investigator: Kenneth Krackow, MD, Buffalo General Hospital, Department of Orthopaedics; Principal Investigator: Sean Scully, MD, Cedars Medical Center University of Miami; Principal Investigator: Mathew Phillips, MD, Buffalo General Hospital, Department of Orthopaedics

Study record dates

Study Major Dates

• Study Start: February 1, 2005
• Primary Completion (Actual): April 1, 2010
• Study Completion (Actual): September 26, 2017

Study Registration Dates

• First Submitted: August 10, 2009
• First Submitted That Met QC Criteria: August 11, 2009
• First Posted (Estimate): August 12, 2009

Study Record Updates

• Last Update Posted (Actual): October 12, 2018
• Last Update Submitted That Met QC Criteria: October 11, 2018
• Last Verified: October 1, 2018

More Information

Terms related to this study

• Other Study ID Numbers: 56